1. Home
  2. MYO vs DARE Comparison

MYO vs DARE Comparison

Compare MYO & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.46

Market Cap

33.3M

Sector

Health Care

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.11

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYO
DARE
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
33.4M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
MYO
DARE
Price
$1.46
$2.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$7.67
$10.00
AVG Volume (30 Days)
1.1M
228.4K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,000,000,000.00
$2,807,885.00
Revenue This Year
$9.10
$2,115.12
Revenue Next Year
$13.59
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
40814.79
N/A
52 Week Low
$0.61
$1.27
52 Week High
$2.83
$9.19

Technical Indicators

Market Signals
Indicator
MYO
DARE
Relative Strength Index (RSI) 64.05 43.02
Support Level $0.76 $1.94
Resistance Level N/A $2.01
Average True Range (ATR) 0.18 0.15
MACD 0.02 -0.02
Stochastic Oscillator 80.65 29.79

Price Performance

Historical Comparison
MYO
DARE

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: